Savara (FRA:YB4P) Ending Cash Position : €18.09 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Savara Ending Cash Position?

Savara's Ending Cash Position for the quarter that ended in Mar. 2025 was €18.09 Mil.

Savara's quarterly Ending Cash Position declined from Sep. 2024 (€19.31 Mil) to Dec. 2024 (€14.45 Mil) but then increased from Dec. 2024 (€14.45 Mil) to Mar. 2025 (€18.09 Mil).

Savara's annual Ending Cash Position declined from Dec. 2022 (€49.18 Mil) to Dec. 2023 (€24.38 Mil) and declined from Dec. 2023 (€24.38 Mil) to Dec. 2024 (€14.45 Mil).

Savara Ending Cash Position Historical Data

The historical data trend for Savara's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara Ending Cash Position Chart

Savara Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

18.81

30.10

49.18

24.38

14.45

Savara Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															15.44	22.17	19.31	14.45	18.09

Savara Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Savara's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	25.389	+	-10.942
	=	14.45

Savara's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13.994	+	4.095
	=	18.09

Savara Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Savara's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Savara Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SVRA:USA YB4P:Germany

Address

1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 19047

Website

https://www.savarapharma.com

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Headlines

No Headlines